Jiangsu Pegasus Pharmaceutical

Jiangsu Pegasus Pharmaceutical Co., Ltd. (also known as Jiangsu Feima Pharmaceutical) is a high-tech pharmaceutical company based in the Nantong Economic and Technological Development Zone, Jiangsu Province, China. Founded in 2003, the company specializes in the research, development, and manufacturing of small molecule active pharmaceutical ingredients (APIs) and solid oral formulations, including tablets, hard capsules, and granules, as well as traditional Chinese medicine (TCM) extractions. Its commercial portfolio features notable products such as pemirolast potassium tablets (Pulimin) for allergies, meloxicam tablets (Prilo) for arthritis, and aspirin/dipyridamole sustained-release capsules (Senage) for stroke prevention. In June 2014, the company was acquired by Suzhou Tianma Pharmaceutical Group Co., Ltd., becoming a wholly-owned subsidiary and integrating into its broader biopharmaceutical and peptide manufacturing ecosystem.